Navigation Links
Stroke Therapy with Corkscrew Device Most Beneficial, Study Suggests
Date:1/18/2010

fers comprehensive treatment. Dedicated stroke training of all key personnel is imperative for a stroke center to be successful.”

Three-Center Stent Study

In a study using stents to treat stroke, the stents opened up the blocked arteries of all 20 patients, and 12 (60 percent) had significant improvement in brain function. On a brain function scale of 0 to 5, with 0 being no brain impairment and 5 being extreme brain impairment, 45 percent of patients scored a 0 or 1 after treatment. Stents generally can reopen arteries much faster than other agents, said L. Nelson Hopkins, M.D., professor and chairman of neurosurgery and professor of radiology at SUNY at Buffalo, who is presenting the research at ISET.

“No device or treatment works for every stroke, but the future is getting brighter for stroke patients because every year there are more and better stroke treatments available,” said Dr. Hopkins. “Stents appear to work in cases where other treatments don’t.”

Dr. Hopkins said the next step is to compare stent treatment for stroke to IV tPA because it is the most widely available interventional stroke treatment.

Co-authors of the study comparing stroke therapies being presented by Dr. Stambo are M.H. Berlet, D. Steffen, K. Van Epps, T. Woeste and C. Kelley.

Co-authors of the study using stents to treat stroke being presented by Dr. Hopkins are E. Levy, A. Siddiqui and J. Mocco.

The International Symposium on Endovascular Therapy (ISET) is attended by more than 1,200 physicians, scientists, allied professionals and industry professionals from around the world. The meeting pioneered the use of live cases to promote the multidisciplinary treatment of cardiac and vascular disease by endovascular means. ISET is presented by the Baptist Cardiac & Vascular Institute, Miami. ISET 2010 is taking place Jan. 17-21 near Miami Beach, Fla.

For more information,
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Cancer, Heart Disease, Stroke, Diabetes, Chronic Pain and Depression Share a Major Pathology Factor
2. D-Pharm Receives FDA Clearance to Commence a Phase III Trial of DP-b99 in Acute Stroke Patients
3. deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
4. PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies
5. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
6. Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation
7. diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players
8. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
9. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
10. Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
11. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Franklin, MA (PRWEB) September 17, 2014 ... pre-engineered version of its TerraPure tank . This ... tanks is molded from FDA-compliant linear polyethylene and available ... seven pre-installed fittings and ships in two weeks or ... same features and benefits found in Terracon’s existing TerraPure ...
(Date:9/17/2014)... SAN FRANCISCO, Calif. , Sept. 17, 2014 /PRNewswire/ ... ), a molecular diagnostics company pioneering the field of ... Hall to chief operating officer. Mr. Hall ... spearhead the company,s commercial entry into endocrinology. Since 2012, ... operations, as well as managed care and billing functions. ...
(Date:9/17/2014)... 17, 2014 First ... from a truly novel class of anti-infective ... Biopharma, a biopharmaceutical company developing a truly ... it has secured £4.0m ($6.4m) to advance ... against a range of Gram-positive infections including  ...
(Date:9/16/2014)... Sept. 16, 2014 This report analyzes the worldwide ... Segments: Software, Hardware, and Biocontent. The report provides separate comprehensive ... Japan , Europe , ... and Rest of World. Annual estimates and forecasts are provided ... analysis is provided for these markets. Market data and analytics ...
Breaking Biology Technology:Terracon Introduces Pre-Engineered TerraPure® Tank for Ultrapure Water Applications 2Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 2Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 3Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 4MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 2MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 3MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 4MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 6MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 7Global Bioinformatics Industry 2Global Bioinformatics Industry 3Global Bioinformatics Industry 4Global Bioinformatics Industry 5Global Bioinformatics Industry 6Global Bioinformatics Industry 7Global Bioinformatics Industry 8Global Bioinformatics Industry 9Global Bioinformatics Industry 10Global Bioinformatics Industry 11Global Bioinformatics Industry 12Global Bioinformatics Industry 13Global Bioinformatics Industry 14Global Bioinformatics Industry 15Global Bioinformatics Industry 16Global Bioinformatics Industry 17Global Bioinformatics Industry 18Global Bioinformatics Industry 19Global Bioinformatics Industry 20Global Bioinformatics Industry 21Global Bioinformatics Industry 22Global Bioinformatics Industry 23
... , , , For quantitative, real-time PCR and two-step RT-PCR using sequence-specific , probes, , ... , Component, Included, ... , , , ... Yes, 2x premixed solution*, , ...
... , , , , For ... , , , , , , ... all reverse transcription with any amount of RNA from 50 ng to 2 ... higher sensitivity and , superior performance even with low copy numbers ...
... , , , , , ... of 139 human cancer-related genes for functional genomics research using , ... , , , , , , ... cancer researchers (see table below for a list of genes). Every siRNA ...
Cached Biology Technology:Cancer siRNA Oligo Set Version 1.0 2Cancer siRNA Oligo Set Version 1.0 3Cancer siRNA Oligo Set Version 1.0 4
(Date:9/17/2014)... plastic shopping bags and their environmental impact recently scored ... first statewide ban on the bags, and Governor Jerry ... bag industry is not yielding without a fight, according ... , the weekly newsmagazine of the American Chemical Society. ... that the anti-bag campaign logged its first small victory ...
(Date:9/17/2014)... have obtained the first partial genome sequence of an ... at the site of the Montsoriu Castle in Girona, ... closely related to today,s Iberian pig. Researchers also discard ... Iberian pigs. , The study, published in Heredity ... species, and particularly on that of the Iberian breed, ...
(Date:9/17/2014)... Researchers at UTSouthwestern Medical Center have found that the ... called apoE3, helps repair the lining of blood vessels. ... the benefit of this repair, putting them at higher ... have identified one mechanism by which apoE3 promotes a ... is detrimental," said Dr. Philip Shaul , Professor ...
Breaking Biology News(10 mins):Iberian pig genome remains unchanged after 5 centuries 2Protein variant may boost cardiovascular risk by hindering blood vessel repair 2
... German . , Research has not proven that the ... off using contraceptive pills because this has been listed ... be narrowing their contraceptive choices without good reason, according ... Health Care (IQWiG). Different forms of contraception have other ...
... around 12 months of age, their brains actually begin ... by the time they start talking, babies actually already ... infants can be a challenging endeavor, researchers have begun ... what infants learn, according to a new report by ...
... Georgetown University Medical Center have discovered a novel way ... the world,s largest-selling breast cancer prevention and treatment drug. ... identify tamoxifen users who are no longer benefiting from ... sooner. , In the November 1 issue of the ...
Cached Biology News:Research shows that the pill does not deserve its reputation for causing weight gain 2Baby talk: The roots of the early vocabulary in infants' learning from speech 2Baby talk: The roots of the early vocabulary in infants' learning from speech 3'New' estrogen receptor found to be key player in tamoxifen resistance 2'New' estrogen receptor found to be key player in tamoxifen resistance 3
Request Info...
Limit of detection: <5 pg/ml...
Request Info...
... the premium quality siRNAs you need for ... be readily ordered online by providing either ... providing the sense and antisense siRNA sequences. ... Silencer Pre-designed siRNAs, which are already designed ...
Biology Products: